Harvard Bioscience (HBIO) EPS (Basic) Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.10 Bn | 129.88 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn |
| 4 | Resmed | 33.98 Bn | 32.51 Bn | 861.22 Mn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn |
| 7 | Solventum | 15.36 Bn | 14.96 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.90 Mn | 27.40 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.48% |
| Mar 31, 2026 | -35.41% |
| Dec 31, 2025 | -28.18% |
| Sep 30, 2025 | 0.72% |
| Jun 30, 2025 | -4.64% |
| Mar 31, 2025 | -57.46% |
| Dec 31, 2024 | -10.68% |
| Dec 31, 2023 | 2.00% |
| Jun 30, 2023 | -92.68% |
| Mar 31, 2023 | -22.14% |
| Dec 31, 2022 | -27.61% |
| Sep 30, 2022 | -70.71% |
| Jun 30, 2022 | 54.02% |
| Mar 31, 2022 | -78.20% |
| Dec 31, 2021 | 22.26% |
| Sep 30, 2021 | 38.58% |
| Jun 30, 2021 | 12.43% |
| Mar 31, 2021 | 2.10% |
| Dec 31, 2020 | 48.58% |
| Sep 30, 2020 | -2.79% |